Annual EBITDA
Summary
- Current Value
- As of today, COO annual EBITDA is $1.11B, down -1.21% on
- Historical Performance
- COO annual EBITDA is up +18.99% over the past 3 years, and up +68.15% over the past 5 years
- All-Time High Comparison
- COO annual EBITDA is currently -1.21% below its historical high of $1.12B set on
- 3-Year Low Comparison
- COO annual EBITDA is +21.66% above its 3-year low of $909.00M reached on
- Sector Comparison
- COO annual EBITDA is higher than 94.05% of companies in Healthcare sector
EBITDA Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.11B | -1.2% | +19.0% | +68.2% | +264.7% | |
| Quarterly EBITDA | $238.80M | -17.5% | +2.3% | +32.4% | +182.2% | |
| TTM EBITDA | $1.06B | -1.9% | +15.1% | +64.6% | +267.5% | |
| Price | $83.45 | -9.2% | -3.0% | -8.1% | +495.3% | |
| PE Ratio | 44.53 | -5.2% | +0.4% | -41.1% | +93.0% | |
| Annual Revenue | $4.09B | +5.1% | +23.7% | +68.3% | +251.6% | |
| Annual EPS | $1.87 | -4.2% | -3.4% | +56.0% | +208.6% | |
| Annual EBIT | $745.20M | +5.6% | +35.2% | +120.4% | +256.1% | |
| Annual Net Income | $374.90M | -4.4% | -2.8% | +57.3% | +232.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.12B | -1.2% | |
| 5Y | $1.12B | -1.2% | |
| All | $1.12B | -1.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $909.00M | +21.7% | |
| 5Y | $657.70M | N/A | +68.2% |
| All | -$28.19M | +4023.7% |
EBITDA History
FAQ
What is the current annual EBITDA of COO?
As of today, COO annual EBITDA is $1.11B
What is 1-year change in COO annual EBITDA?
COO annual EBITDA is down -1.21% year-over-year
What is 3-year change in COO annual EBITDA?
COO annual EBITDA is up +18.99% over the past 3 years
How far is COO annual EBITDA from its all-time high?
COO annual EBITDA is currently -1.21% below its historical high of $1.12B set on October 31, 2024
How does COO annual EBITDA rank versus sector peers?
COO annual EBITDA is higher than 94.05% of companies in Healthcare sector
When is COO next annual earnings release?
As of today, the next annual earnings release for COO has not been scheduled
Quarterly EBITDA
Summary
- Current Value
- As of today, COO quarterly EBITDA is $238.80M, down -11.91% on
- Historical Performance
- COO quarterly EBITDA is down -17.48% year-over-year, and up +2.27% over the past 3 years
- All-Time High Comparison
- COO quarterly EBITDA is currently -17.48% below its historical high of $289.40M set on
- 3-Year Low Comparison
- COO quarterly EBITDA is +27.63% above its 3-year low of $187.10M reached on
- Sector Comparison
- COO quarterly EBITDA is higher than 92.76% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $238.80M | -11.9% | -17.5% | +2.3% | +32.4% | |
| Annual EBITDA | $1.11B | – | -1.2% | +19.0% | +68.2% | |
| TTM EBITDA | $1.06B | -4.5% | -1.9% | +15.1% | +64.6% | |
| Price | $83.45 | +19.6% | -9.2% | -3.0% | -8.1% | |
| PE Ratio | 44.53 | +29.7% | -5.2% | +0.4% | -41.1% | |
| Quarterly Revenue | $1.07B | +0.5% | +4.6% | +25.6% | +56.3% | |
| Quarterly EPS | $0.43 | -13.1% | -26.9% | +29.2% | +4.3% | |
| Quarterly EBIT | $178.20M | +1.4% | -10.2% | +58.7% | +72.5% | |
| Quarterly Net Income | $84.60M | -13.9% | -28.0% | +29.0% | +4.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $289.40M | N/A | -17.5% |
| 3Y | $289.40M | -17.5% | |
| 5Y | $289.40M | -17.5% | |
| All | $289.40M | -17.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $238.80M | at low | |
| 3Y | $187.10M | +27.6% | |
| 5Y | $180.40M | N/A | +32.4% |
| All | -$428.30M | +155.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of COO?
As of today, COO quarterly EBITDA is $238.80M
What is COO quarterly EBITDA most recent change?
COO quarterly EBITDA was down -11.91% on October 31, 2025
What is 1-year change in COO quarterly EBITDA?
COO quarterly EBITDA is down -17.48% year-over-year
How far is COO quarterly EBITDA from its all-time high?
COO quarterly EBITDA is currently -17.48% below its historical high of $289.40M set on October 31, 2024
How does COO quarterly EBITDA rank versus sector peers?
COO quarterly EBITDA is higher than 92.76% of companies in Healthcare sector
When is COO next earnings release?
The next earnings release for COO is on
TTM EBITDA
Summary
- Current Value
- As of today, COO TTM EBITDA is $1.06B, down -4.55% on
- Historical Performance
- COO TTM EBITDA is down -1.90% year-over-year, and up +15.10% over the past 3 years
- All-Time High Comparison
- COO TTM EBITDA is currently -5.44% below its historical high of $1.12B set on
- 3-Year Low Comparison
- COO TTM EBITDA is +20.16% above its 3-year low of $882.40M reached on
- Sector Comparison
- COO TTM EBITDA is higher than 93.48% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.06B | -4.5% | -1.9% | +15.1% | +64.6% | |
| Annual EBITDA | $1.11B | – | -1.2% | +19.0% | +68.2% | |
| Quarterly EBITDA | $238.80M | -11.9% | -17.5% | +2.3% | +32.4% | |
| Price | $83.45 | +19.6% | -9.2% | -3.0% | -8.1% | |
| PE Ratio | 44.53 | +29.7% | -5.2% | +0.4% | -41.1% | |
| TTM Revenue | $4.09B | +1.2% | +5.1% | +23.7% | +68.3% | |
| TTM EPS | $1.87 | -7.7% | -4.2% | -3.5% | +56.0% | |
| TTM EBIT | $720.70M | -2.7% | +2.1% | +32.8% | +101.8% | |
| TTM Net Income | $374.90M | -8.1% | -4.4% | -2.9% | +57.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.12B | -5.4% | |
| 3Y | $1.12B | -5.4% | |
| 5Y | $1.12B | -5.4% | |
| All | $1.12B | -5.4% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.06B | at low | |
| 3Y | $882.40M | +20.2% | |
| 5Y | $644.20M | N/A | +64.6% |
| All | -$388.90M | +372.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of COO?
As of today, COO TTM EBITDA is $1.06B
What is COO TTM EBITDA most recent change?
COO TTM EBITDA was down -4.55% on October 31, 2025
What is 1-year change in COO TTM EBITDA?
COO TTM EBITDA is down -1.90% year-over-year
How far is COO TTM EBITDA from its all-time high?
COO TTM EBITDA is currently -5.44% below its historical high of $1.12B set on April 30, 2025
How does COO TTM EBITDA rank versus sector peers?
COO TTM EBITDA is higher than 93.48% of companies in Healthcare sector
When is COO next earnings release?
The next earnings release for COO is on
EBITDA Formula
Data Sources & References
- COO Official Website www.coopercos.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/711404/000162828025055615/0001628280-25-055615-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/711404/000162828025055615/0001628280-25-055615-index.htm
- COO Profile on Yahoo Finance finance.yahoo.com/quote/COO
- COO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coo
